Physician profile
Kenneth T Thunder
NPI 1518929967
$1,413.16
in general payments reported to CMS, 2019-2025
17 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.03 · 2020: $26.20 · 2021: $28.98 · 2022: $58.96 · 2023: $544 · 2024: $286 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $473.50 | 2023-2025 | Spravato |
| Abbvie INC. | $276.23 | 2023-2025 | Ubrelvy, Qulipta |
| Averitas Pharma INC. | $154.75 | 2023-2024 | Qutenza |
| Pfizer INC. | $90.73 | 2023-2025 | |
| Lundbeck LLC | $88.97 | 2022-2024 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $60.25 | 2025 | |
| Collegium Pharmaceutical, INC. | $47.11 | 2019-2021 | |
| Lilly USA, LLC | $34.15 | 2021-2023 | Emgality |
| Mdd US Operations, LLC | $30.17 | 2019-2020 | |
| Tonix Medicines, INC. | $28.82 | 2025 | Tonmya |
| Abbott Laboratories | $25.97 | 2025 | Proclaim |
| Depuy Synthes Sales INC. | $22.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.82 | 2019 | |
| Merz Pharmaceuticals, LLC | $19.80 | 2023 | Xeomin |
| Zyla Life Sciences, INC. | $17.38 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $13.89 | 2020 | |
| Neuronetics, INC. | $9.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Thunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.